| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients
|
Alsina, Maria
|
|
2017
|
13 |
1 |
p. 69-78
|
article
|
| 2 |
Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients
|
Alsina, Maria
|
|
2017
|
13 |
1 |
p. 79
|
article
|
| 3 |
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial
|
Harada, Kazuto
|
|
2017
|
13 |
1 |
p. 99-106
|
article
|
| 4 |
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
|
Clarke, Jeffrey M.
|
|
2018
|
13 |
1 |
p. 1-20
|
article
|
| 5 |
Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review
|
Chovanec, Michal
|
|
2017
|
13 |
1 |
p. 49-60
|
article
|
| 6 |
Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions
|
Vijayaraghavan, Smruthi
|
|
2017
|
13 |
1 |
p. 21-38
|
article
|
| 7 |
Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program
|
Pulley, Jill M.
|
|
2017
|
13 |
1 |
p. 61-68
|
article
|
| 8 |
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC
|
McKeage, Mark J.
|
|
2017
|
13 |
1 |
p. 89-98
|
article
|
| 9 |
Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
|
Martin-Liberal, Juan
|
|
2017
|
13 |
1 |
p. 81-87
|
article
|
| 10 |
The Role of B-Cell Maturation Antigen in the Biology and Management of, and as a Potential Therapeutic Target in, Multiple Myeloma
|
Sanchez, Eric
|
|
2017
|
13 |
1 |
p. 39-47
|
article
|
| 11 |
Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study
|
Zaanan, Aziz
|
|
2017
|
13 |
1 |
p. 107-112
|
article
|
Journal description